Little is known about the differences between the lesion features of the recently discovered MOG-ab-positive and well-demonstrated AQP4-ab-positive patients till now. We studied the radiomics features of 747 lesions from AQP4 patients, and 295 lesions from MOG patients. Seventy radiomic features were calculated and compared. Features with significant between-group discrimination ability input to the classifier and trained. A radiomics signature was obtained for the discrimination of MOG-ab-positive and AQP4-ab-positive patients. These results provide valuable information for understanding of pathogenesis and imaging-based initial diagnosis in the two subsets of patients.
Fifty-seven and thirty-three clinical MR examinations were performed on fifty-two AQP4-ab-positive and twenty-eight MOG-ab-positive patients, respectively. Hyper-intense T2 lesions were segmented manually on each axial FLAIR image. Each spatially connected cluster was extracted and treated as an independent volume-of-interest (VOI). Three-quarters of these lesions (781 lesions) were assigned as discovery set, and the others (261 lesions) were assigned as validation set.
Radiomic features, including 14 first-order statistical features and 56 texture features, were calculated for each lesion [1][2]. Redundant features were eliminated according to the feature correlation matrix. Features with a between-group discrimination significance of P < 0.05 using Wilcoxon rank-sum test were selected and input to the classifier, least absolute shrinkage and selection operator (LASSO), to build a radiomic signature for the discrimination of AQP4 and MOG. LASSO was trained using 10-fold cross-validation on the discovery set. Then, the most useful predictive features and their weights were determined, and radiomics score (Rad-score) was calculated for each lesion. The discrimination ability of the radiomics signature was tested on the validation dataset and assessed by receiver operating characteristic (ROC) curve analysis and quantified by the area under the ROC curve (AUC). The point on the discovery ROC curve that was closest to the upper left corner was selected as the cutoff, and the corresponding accuracy, sensitivity, and specificity values were calculated for both discovery and validation set.
[1] Xia W, Chen Y, Zhang R et al (2018) Radiogenomics of hepatocellular carcinoma: multiregion analysis-based identification of prognostic imaging biomarkers by integrating gene data-a preliminary study. Physics in Medicine and Biology 63
[2] Vallieres M, Freeman CR, Skamene SR, El Naqa I (2015) A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Physics in Medicine and Biology 60:5471-5496